Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial
- 10 August 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (23) , 5404-5405
- https://doi.org/10.1200/jco.2005.05.189
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A phase I study of DX 8951f (exatecan mesylate for injection) in patients with renal dysfunctionJournal of Clinical Oncology, 2004
- Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapyAnnals of Surgical Oncology, 2002
- D2 or not D2? The gastrectomy questionGastric Cancer, 2002
- The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancerSurgery, 2002
- Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.Journal of Clinical Oncology, 1998
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984